Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Cash from Financing Activities (2022 - 2025)

Gossamer Bio (GOSS) has 4 years of Cash from Financing Activities data on record, last reported at $1.9 million in Q3 2025.

  • For Q3 2025, Cash from Financing Activities rose 566.19% year-over-year to $1.9 million; the TTM value through Sep 2025 reached $2.5 million, up 117.16%, while the annual FY2024 figure was -$11.5 million, 106.04% down from the prior year.
  • Cash from Financing Activities reached $1.9 million in Q3 2025 per GOSS's latest filing, up from $94000.0 in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $198.5 million in Q3 2023 and bottomed at -$9.2 million in Q2 2024.
  • Average Cash from Financing Activities over 4 years is $21.3 million, with a median of $57500.0 recorded in 2022.
  • Peak YoY movement for Cash from Financing Activities: plummeted 13928.57% in 2023, then soared 566.19% in 2025.
  • A 4-year view of Cash from Financing Activities shows it stood at -$2.9 million in 2022, then fell by 1.04% to -$2.9 million in 2023, then soared by 109.68% to $281000.0 in 2024, then skyrocketed by 566.19% to $1.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Financing Activities were $1.9 million in Q3 2025, $94000.0 in Q2 2025, and $504000.0 in Q1 2025.